HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)

National Institutes of Health

Federal funding opportunity RFA-NS-27-007 published by National Institutes of Health. Review the official synopsis for eligibility, award terms, and application requirements.